{"transactions":[{"id":737397,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38024,"kind":"person","name":"Twyman Roy Ervin","position":1,"cik":"0002117542","reported_name":"Twyman Roy Ervin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-15T11:10:27.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":38889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 11, 2026, the Reporting Person received share options with respect to 38,889 shares under the SOIP. The share options will fully vest on June 10, 2027."}],"balance_after":38889,"derivative":{"exercise_price":2.62,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Share","underlying_shares":38889},"source":{"system":"sec-edgar","filing":"0001651625-26-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000012/primary_doc.xml","form_type":"4"}},{"id":737396,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38024,"kind":"person","name":"Twyman Roy Ervin","position":1,"cik":"0002117542","reported_name":"Twyman Roy Ervin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Share","published_at":"2026-06-15T11:10:27.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":16568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2026, the Reporting Person received a restricted share unit grant of 16,568 units under the AC Immune SA 2016 Stock Option and Incentive Plan (SOIP)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 66,556 common shares underlying outstanding restricted share units."}],"balance_after":92556,"source":{"system":"sec-edgar","filing":"0001651625-26-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000012/primary_doc.xml","form_type":"4"}},{"id":737431,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38035,"kind":"person","name":"AGUIAR-LUCANDER RENEE","position":1,"cik":"0001591617","reported_name":"AGUIAR-LUCANDER RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-15T10:59:24.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":38889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 11, 2026, the Reporting Person received share options with respect to 38,889 shares under the SOIP. The share options will fully vest on June 10, 2027."}],"balance_after":38889,"derivative":{"exercise_price":2.62,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Share","underlying_shares":38889},"source":{"system":"sec-edgar","filing":"0001651625-26-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1591617/000165162526000011/primary_doc.xml","form_type":"4"}},{"id":737430,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38035,"kind":"person","name":"AGUIAR-LUCANDER RENEE","position":1,"cik":"0001591617","reported_name":"AGUIAR-LUCANDER RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Share","published_at":"2026-06-15T10:59:24.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":16568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Reporting Person received a restricted share unit grant of 16,568 units under the AC Immune SA 2016 Stock Option and Incentive Plan (SOIP)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Comprised of 51,136 common shares underlying outstanding restricted share units."}],"balance_after":51136,"source":{"system":"sec-edgar","filing":"0001651625-26-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1591617/000165162526000011/primary_doc.xml","form_type":"4"}},{"id":737748,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38163,"kind":"person","name":"Zuegel Martin","position":1,"cik":"0001484988","reported_name":"Zuegel Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Share Option (right to buy)","published_at":"2026-06-15T10:50:18.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":77778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 11, 2026, the Reporting Person received share options with respect to 77,778 shares under the SOIP. The share options will fully vest on June 10, 2027."}],"balance_after":77778,"derivative":{"exercise_price":2.62,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Share","underlying_shares":77778},"source":{"system":"sec-edgar","filing":"0001651625-26-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484988/000165162526000010/primary_doc.xml","form_type":"4"}},{"id":737747,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38163,"kind":"person","name":"Zuegel Martin","position":1,"cik":"0001484988","reported_name":"Zuegel Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Share","published_at":"2026-06-15T10:50:18.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Reporting Person received a restricted share unit grant of 33,136 units under the AC Immune SA 2016 Stock Option and Incentive Plan (SOIP)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Comprised of 71,408 common shares underlying outstanding restricted share units."}],"balance_after":71408,"source":{"system":"sec-edgar","filing":"0001651625-26-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484988/000165162526000010/primary_doc.xml","form_type":"4"}},{"id":737395,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38023,"kind":"person","name":"Buetler Monika","position":1,"cik":"0002115138","reported_name":"Buetler Monika","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-15T10:40:30.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 11, 2026, the Reporting Person received share options with respect to 41,667 shares under the SOIP. The share options will fully vest on June 10, 2027."}],"balance_after":41667,"derivative":{"exercise_price":2.62,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Share","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001651625-26-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000009/primary_doc.xml","form_type":"4"}},{"id":737394,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38023,"kind":"person","name":"Buetler Monika","position":1,"cik":"0002115138","reported_name":"Buetler Monika","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Share","published_at":"2026-06-15T10:40:30.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":17751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Reporting Person received a restricted share unit grant of 17,751 units under the AC Immune SA 2016 Stock Option and Incentive Plan (SOIP)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,656 common shares underlying outstanding restricted share units."}],"balance_after":71656,"source":{"system":"sec-edgar","filing":"0001651625-26-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000009/primary_doc.xml","form_type":"4"}},{"id":737391,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38021,"kind":"person","name":"June Carl Howard","position":1,"cik":"0002116422","reported_name":"June Carl Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-15T10:31:33.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":38889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 11, 2026, the Reporting Person received share options with respect to 38,889 shares under the SOIP. The share options will fully vest on June 10, 2027."}],"balance_after":38889,"derivative":{"exercise_price":2.62,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Share","underlying_shares":38889},"source":{"system":"sec-edgar","filing":"0001651625-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000008/primary_doc.xml","form_type":"4"}},{"id":737390,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":38021,"kind":"person","name":"June Carl Howard","position":1,"cik":"0002116422","reported_name":"June Carl Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Share","published_at":"2026-06-15T10:31:33.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":16568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Reporting Person received a restricted share unit grant of 16,568 units under the AC Immune SA 2016 Stock Option and Incentive Plan (SOIP)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 66,556 common shares underlying outstanding restricted share units."}],"balance_after":67556,"source":{"system":"sec-edgar","filing":"0001651625-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000008/primary_doc.xml","form_type":"4"}},{"id":774306,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":46308,"kind":"person","name":"Pfeifer Andrea","position":1,"cik":"0001697107","reported_name":"Pfeifer Andrea","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share","published_at":"2026-05-18T20:25:40.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":2.7935,"value":27935.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.825. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,921,005 common shares underlying outstanding restricted share units."}],"balance_after":3820288,"source":{"system":"sec-edgar","filing":"0001651625-26-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000007/primary_doc.xml","form_type":"4"}},{"id":806828,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":46308,"kind":"person","name":"Pfeifer Andrea","position":1,"cik":"0001697107","reported_name":"Pfeifer Andrea","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share","published_at":"2026-04-16T16:39:29.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":3.1425,"value":31425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A amends the Form 4 filed on April 16, 2026, inadvertently reporting in column 3 a purchase of 10,000 shares on behalf of the reporting person. This amendment corrects that filing to reflect that the reporting person sold 10,000 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.19, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,921,005 common shares underlying outstanding restricted share units."}],"balance_after":3830288,"source":{"system":"sec-edgar","filing":"0001651625-26-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000006/primary_doc.xml","form_type":"4/A","original_submission_date":"2026-04-16"}},{"id":806827,"issuer":{"id":6075,"kind":"organization","name":"AC Immune SA","symbol":"ACIU"},"owners":[{"id":46308,"kind":"person","name":"Pfeifer Andrea","position":1,"cik":"0001697107","reported_name":"Pfeifer Andrea","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share","published_at":"2026-04-16T15:10:49.000Z","date":"2026-04-15","kind":"purchase","planned":true,"acquired":false,"shares":10000,"price":3.1425,"value":31425.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.05 to $3.19, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,921,005 common shares underlying outstanding restricted share units."}],"balance_after":3830288,"source":{"system":"sec-edgar","filing":"0001651625-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651625/000165162526000005/primary_doc.xml","form_type":"4"}}]}